It is an American public pharmaceutical organization with their Head Offices based in Cranbury, New Jersey. In 2007 Amicus Therapeutics was officially launched with a trade name FOLD under NASDAQ. The group was established to primarily deal with orphan as well as rare diseases in particular disorders which are known as lysosomal storage disorders. The healthcare company had not marketed their products by 2014, and they only had advanced candidate migalastat which goes by the brand name of Galafold. Galafold is a treatment for Fabry disease. Amicus Therapeutics chief candidate migalastat advanced, and then pharmaceutical firm expanded their market with them collaborating with one of the top pharmaceutical companies in the world; GlaxoSmithKline, and JCR Pharmaceuticals. The collaboration only lasted for three years.
From the time the organization was founded they have been expanding their portfolio with them establishing their operations in other regions including, San Diego. After facing a financial crisis in 2009, Amicus Therapeutics receive financial support of about $500000 from the Michael J. Fox Foundation to support the research which was being conducted together with David Geffen School of Medicine UCLA. The Michael J. Fox Foundation was not the only group that supported Amicus Therapeutics. The firm also received donations from Alzheimer’s Drug Discovery Foundation. The funding was to support the pre-clinical work that the firm was carrying out with Icahn School of Medicine AT Mount Sinai. Read more at seeking.com about Amicus Therapeutics.
Like any other organization, Amicus Therapeutics is also devoted to distributing their services as well as products with honesty. The medical company has been working with a strong direction from their Chief Executive Officer, their Chairman as well as their Board of Directors. The able team members of the firm respect each other, as they support one another to accomplish their long-term and personal goals as well as those of the organization. It is the management’s as well as the experienced team’s effort to make Amicus Therapeutics one of the leaders in the pharmaceutical industry. Learn more about Amicus Therapeutics at Dial Dish.